• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

ViiV Healthcare reports data from Phase I trial of HIV drug

cafead

Administrator
Staff member
  • cafead   Mar 05, 2024 at 11:22: AM
via UK-based pharmaceutical company ViiV Healthcare has reported data from a Phase I trial of its investigational formulation, cabotegravir ultra long-acting (CAB-ULA), for HIV treatment and prevention.

article source
 

<